ConductScience.org, home

Paper36933639

Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint.

Alqurashi YE and 9 others. Environ Res, 2023. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint. Papers, record 36933639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36933639

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint.
PubMed
Journal
Environ Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
3.52
iCite
Revised in PubMed
2023-05-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alqurashi YEYaser E
2Al-Hetty HRAKHussein Riyadh Abdul Kareem
3Ramaiah PPushpamala
4Fazaa AHAlaa Hameed
5Jalil ATAbduladheem Turki
6Alsaikhan FFahad
7Gupta JJitendra
8Ramírez-Coronel AAAndrés Alexis
9Tayyib NANahla A
10Peng HHu

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Humans
Epithelial-Mesenchymal Transition
Epithelial Cells
Cell Transformation, Neoplastic
Cell Line, Tumor

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42984920Small Molecule Targeted Therapy for Hepatocellular Carcinoma: From Multikinase Inhibition to Cancer Stem Cell Eradication Strategies.Oncol Res2026https://conductscience.org/library/papers/42984920PubMed
42758381NHSL3 knockout modulates sorafenib response, growth, and motility in hepatocellular carcinoma cell models.Mol Biol Rep2026https://conductscience.org/library/papers/42758381PubMed
41953013Investigating the role of the TGF-β-SLC20A1 axis in the spatial heterogeneity of hepatocellular carcinoma through single-cell and spatial transcriptomics.Front Immunol2026https://conductscience.org/library/papers/41953013PubMed
41879446Bee Venom and Cancer: A Mini-review Focusing on Melittin Antitumoral Effects.Curr Drug Targets2026https://conductscience.org/library/papers/41879446PubMed
41578333Sorafenib nanomedicine in HCC: nano-bio interactions and combination therapies.J Nanobiotechnology2026https://conductscience.org/library/papers/41578333PubMed
41572799Extracellular Vesicles in Liver Disease: Redefining Diagnostic and Therapeutic Strategies.Int J Stem Cells2026https://conductscience.org/library/papers/41572799PubMed
41491521
Integrating single cell- and spatial- resolved transcriptomics unravels the inter-tumor heterogeneity and immunosuppressive landscape in HBV- and Clonorchis sinensis-associated hepatocellular carcinoma.
Mol Cancer2026https://conductscience.org/library/papers/41491521PubMed
41277807RBMX2 links Mycobacterium bovis infection to epithelial-mesenchymal transition and lung cancer progression.Elife2025https://conductscience.org/library/papers/41277807PubMed
41149589A Robust Marine Collagen Peptide-Agarose 3D Culture System for In Vitro Modeling of Hepatocellular Carcinoma and Anti-Cancer Therapeutic Development.Mar Drugs2025https://conductscience.org/library/papers/41149589PubMed
40862712Multi-Omic Characterization of Epithelial-Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma.Cells2025https://conductscience.org/library/papers/40862712PubMed
40556662Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma.BME Front2025https://conductscience.org/library/papers/40556662PubMed
40312502RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP/PKA/CREB signaling pathway.J Cancer Res Clin Oncol2025https://conductscience.org/library/papers/40312502PubMed
40260291Mechanistic studies and therapeutic potential of angiopoietin in head and neck tumor angiogenesis.Front Oncol2025https://conductscience.org/library/papers/40260291PubMed
40192866Insights into the history and trends of nanotechnology for the treatment of hepatocellular carcinoma: a bibliometric-based visual analysis.Discov Oncol2025https://conductscience.org/library/papers/40192866PubMed
40038747MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3.J Transl Med2025https://conductscience.org/library/papers/40038747PubMed
39764737The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO.Cancer Rep (Hoboken)2025https://conductscience.org/library/papers/39764737PubMed
39532948A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease.Sci Rep2024https://conductscience.org/library/papers/39532948PubMed
39498055Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.Heliyon2024https://conductscience.org/library/papers/39498055PubMed
39267682Nrf2 in human cancers: biological significance and therapeutic potential.Am J Cancer Res2024https://conductscience.org/library/papers/39267682PubMed
39062458AGR2: The Covert Driver and New Dawn of Hepatobiliary and Pancreatic Cancer Treatment.Biomolecules2024https://conductscience.org/library/papers/39062458PubMed

See all 22 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SNAI16615PubTator's text mininghttps://conductscience.org/library/genes/6615NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TWIST17291PubTator's text mininghttps://conductscience.org/library/genes/7291NCBI Gene
ZEB16935PubTator's text mininghttps://conductscience.org/library/genes/6935NCBI Gene
ZEB29839PubTator's text mininghttps://conductscience.org/library/genes/9839NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36933639

GET https://conductscience.org/api/papers/v1/36933639/cited_by?page=2